These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 6053557)

  • 1. Studies on the murine plasma-cell neoplasm, X5563. II. Accelerated immunologic reactivity to transplanted tumor induced in C3H mice by transferred immune rabbit cells.
    Gordon BL II; Fong J
    Ann Allergy; 1967 Sep; 25(9):471-82. PubMed ID: 6053557
    [No Abstract]   [Full Text] [Related]  

  • 2. The formalinization of antibody to tumor cells in altering the immune response.
    Ungaro PC; Drake WP; Mardiney MR
    Cancer Res; 1972 Oct; 32(10):2241-7. PubMed ID: 4117036
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for several cell populations active in antibody dependent cellular cytotoxicity.
    Zighelboim J; Bonavida B; Fahey JL
    J Immunol; 1973 Dec; 111(6):1737-42. PubMed ID: 4750865
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in the electrophoretic mobility of mouse lymphocytes, thymocytes, macrophages and tumour cells following immunisation.
    Hartveit F; Cater DB; Mehrishi JN
    Br J Exp Pathol; 1968 Dec; 49(6):634-47. PubMed ID: 5706992
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunologic aspects of murine allogeneic tumor growth (author's transl)].
    Braun M; Saal F; Pasqualini CD
    Sangre (Barc); 1974; 19(2):153-7. PubMed ID: 4409784
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of immunologic activity of host in radiotherapy].
    Tsuchiya T
    Gan No Rinsho; 1983 Oct; 29(13):1499-505. PubMed ID: 6608014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen driven selection for Fc receptors of enhancing antibody on macrophages during an alloimmune response.
    Whitten HD; Cruse JM; Lewis GK; Watson ES
    J Reticuloendothel Soc; 1974 Feb; 15(2):118-25. PubMed ID: 4815211
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cytotoxic immunity indices of melanoma B16 growth in mice].
    Korosteleva TA; Veresova OV
    Vopr Onkol; 1980; 26(1):67-70. PubMed ID: 7355591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological enhancement as studied by cell culture techniques.
    Hellström KE; Hellström I
    Annu Rev Microbiol; 1970; 24():373-98. PubMed ID: 4927135
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of abdominal transplanted mammary tumor on peritoneal fluid cytology in mice.
    Davis RH; Sackman JW; Kramer DL; Balin H
    Obstet Gynecol; 1975 Feb; 45(2):190-2. PubMed ID: 1118092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum factors that inhibit in vitro immunological reactions in malignant tumor development in experimental animals].
    Lomakin MS; Larin AS; Mamaeva TN; Levitina VL
    Vopr Onkol; 1977; 23(10):76-82. PubMed ID: 202095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Isolation of tumor-localizing antibodies using immunosorbents. II. Isolation of heterologous antibodies against a mouse tumor, induced by UV radiation].
    Teichmann B; Vogt R
    Arch Geschwulstforsch; 1973; 42(4):285-97. PubMed ID: 4808121
    [No Abstract]   [Full Text] [Related]  

  • 13. Transplantation of primary plasma cell tumor without 2,6,10,14- tetramethylpentadecane (pristane) treatment of the hosts.
    Platica M; Bojko C; Hollander VP
    Cancer Res; 1980 Mar; 40(3):579-81. PubMed ID: 7471077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction and inhibition of host immunity to experimental neoplasms. Discussion.
    Br J Cancer Suppl; 1973 Aug; 1():62-71. PubMed ID: 4804291
    [No Abstract]   [Full Text] [Related]  

  • 15. Facilitation of macrophage-mediated destruction of allogeneic fibrosarcoma cells by tumor-enhancing IgG 2 in vitro.
    Cruse JM; Whitten HD; Lewis GK; Watson ES
    Transplant Proc; 1973 Mar; 5(1):961-7. PubMed ID: 4695960
    [No Abstract]   [Full Text] [Related]  

  • 16. [Variations of cellular type specific immunological defense mechanisms as a function of tumor growth].
    Barski G; Youn JK; Belehradek J; Le François D
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):633-43. PubMed ID: 5050873
    [No Abstract]   [Full Text] [Related]  

  • 17. The induction of a fatal desmoplastic mesothelial reaction in rabbits with mouse Ehrlich ascites carcinomata.
    Sinai Y; Reesal MR
    J Pathol; 1974 Mar; 112(3):129-37. PubMed ID: 4209683
    [No Abstract]   [Full Text] [Related]  

  • 18. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo.
    Gabizon A; Leibovich SJ; Goldman R
    J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultraviolet radiation and tumor immunity.
    Kripke ML
    J Reticuloendothel Soc; 1977 Sep; 22(3):217-22. PubMed ID: 926083
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunological properties of malignant and nonmalignant sublines of L-cells.
    Lavrovsky VA; Viksler VK
    Cancer Res; 1980 Sep; 40(9):3252-8. PubMed ID: 7427939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.